1h Free Analyst Time
The Biopsy Guidance System Market size was estimated at USD 1.44 billion in 2023, USD 1.54 billion in 2024, and is expected to grow at a CAGR of 7.34% to reach USD 2.38 billion by 2030.The biopsy guidance system market encompasses the sales and development of medical devices and software that assist physicians in accurately locating the site for biopsy procedures. These biopsy guidance systems utilize a variety of modalities such as ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), and other image-guided technologies to provide real-time assistance in accurately locating and targeting abnormal tissue for a biopsy. The growing incidences of cancer and gastrointestinal diseases is increasing the need for biopsy guidance systems. The rising awareness of breast cancer treatment & diagnosis and increasing preference for minimally invasive biopsy treatments has significantly contributing to the market growth. However, high cost associated with the production of biopsy guidance systems may limit the adoption of biopsy guidance systems. Technical complexities associated with biopsy guidance systems are also a concerning factor for the market growth. Moreover, the technological advancements in biopsy guidance systems is expected to create significant growth potential in the market. Improved healthcare infrastructure and healthcare spending are also anticipated to generate attractive opportunities for the market growth. Speak directly to the analyst to clarify any post sales queries you may have.
Regional Insights
The Americas region is characterized by the presence of advanced healthcare infrastructure, higher healthcare spending, and a greater emphasis on early diagnosis and personalized medicine, which fuels the need for sophisticated biopsy guidance systems. Additionally, this region remains a hub for innovative startups and established companies seeking to improve the performance of cancer diagnostics. The European Union is associated with the widespread adoption of biopsy guidance systems due to the region's strong healthcare policies and well-established reimbursement frameworks. There is an emphasis on quality healthcare with a focus on advanced medical devices. The EU's regulatory environment also supports innovation through funding initiatives and facilitates research collaborations between private and public players. Asia Pacific is a rapidly growing region in the biopsy guidance system market. In China, large-scale investments in healthcare and growing public awareness about cancer are key factors propelling the need for biopsy guidance systems. The Chinese government's initiatives to reform healthcare and emphasis on emerging medical technologies have driven the adoption of advanced biopsy systems. Technological innovation, high healthcare standards, and a rapidly aging population drive Japan's need for biopsy guidance systems.FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Biopsy Guidance System Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biopsy Guidance System Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.Key Company Profiles
The report delves into recent significant developments in the Biopsy Guidance System Market, highlighting leading vendors and their innovative profiles. These include Argon Medical Devices, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biobot Surgical Pte Ltd., Body Vision Medical Ltd., Boston Scientific Corporation, Cardinal Health, Inc., Cook Group Incorporated, Danaher Corporation, Fujifilm Holdings Corporation, GE Healthcare, Hologic, Inc., IMS Giotto S.p.A, Inomed Health Limited, INRAD Inc., IZI Medical Products, KOELIS, Koninklijke Philips N.V., KPI Healthcare India pvt Ltd, Mauna Kea Technologies, Medtronic PLC, Merit Medical Systems, NeoDynamics AB, Olympus Corporation, Planmed Oy, Siemens Healthineers AG, STERYLAB S.r.l., Stryker Corporation, and Trivitron Healthcare.Market Segmentation & Coverage
This research report categorizes the Biopsy Guidance System Market to forecast the revenues and analyze trends in each of the following sub-markets:- Product
- MRI Guided Biopsy
- Stereotactic Guided Biopsy
- Ultrasound Guided Biopsy
- Application
- Brain Biopsy
- Breast Biopsy
- Lungs
- Prostate
- End-Use
- Diagnostic Centers
- Hospitals
- Research & Academic Institutes
- Specialty Clinics
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
- What is the market size and forecast of the Biopsy Guidance System Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biopsy Guidance System Market?
- What are the technology trends and regulatory frameworks in the Biopsy Guidance System Market?
- What is the market share of the leading vendors in the Biopsy Guidance System Market?
- Which modes and strategic moves are suitable for entering the Biopsy Guidance System Market?
Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.
This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
5. Market Insights
6. Biopsy Guidance System Market, by Product
7. Biopsy Guidance System Market, by Application
8. Biopsy Guidance System Market, by End-Use
9. Americas Biopsy Guidance System Market
10. Asia-Pacific Biopsy Guidance System Market
11. Europe, Middle East & Africa Biopsy Guidance System Market
12. Competitive Landscape
13. Competitive Portfolio
14. Appendix
List of Figures
List of Tables
Companies Mentioned
- Argon Medical Devices, Inc.
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Biobot Surgical Pte Ltd.
- Body Vision Medical Ltd.
- Boston Scientific Corporation
- Cardinal Health, Inc.
- Cook Group Incorporated
- Danaher Corporation
- Fujifilm Holdings Corporation
- GE Healthcare
- Hologic, Inc.
- IMS Giotto S.p.A
- Inomed Health Limited
- INRAD Inc.
- IZI Medical Products
- KOELIS
- Koninklijke Philips N.V.
- KPI Healthcare India pvt Ltd
- Mauna Kea Technologies
- Medtronic PLC
- Merit Medical Systems
- NeoDynamics AB
- Olympus Corporation
- Planmed Oy
- Siemens Healthineers AG
- STERYLAB S.r.l.
- Stryker Corporation
- Trivitron Healthcare
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 198 |
| Published | March 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 1.54 Billion |
| Forecasted Market Value ( USD | $ 2.38 Billion |
| Compound Annual Growth Rate | 7.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 29 |
